European Journal of Endocrinology: Foreword

European Journal of Endocrinology

Volumn 161, Issue SUPPL. 1, 2009, Pages

  Wilton, Patrick ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; PEGVISOMANT; RECOMBINANT GROWTH HORMONE;

ACROMEGALY; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; EDITORIAL; ENDOCRINE DISEASE; EVIDENCE BASED MEDICINE; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HIGH RISK POPULATION; HUMAN; OUTCOME ASSESSMENT; PEER REVIEW; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; RANDOMIZATION;

EID: 70449793523     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0841     Document Type: Editorial

References (9)

1. Concato J. Observational versus experimental studies. What is the evidence for hierarchy? Journal of the American Society for Experimental Neuro Therapeutics 2004 1 341-347.
2. Horwitz R, Viscoli C, Clemens J & Sadock R. Developing improved observational methods for evaluating therapeutic effectiveness. American Journal of Medicine 1990 89 630-638. (Pubitemid 20384321)
3. Grodstein F, Clarkson T & Manson J. Understanding the divergent data on postmenopausal therapy. New England Journal of Medicine 2003 348 645-650. (Pubitemid 36204960)
4. Concato J, Shah N & Horwitz R. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New England Journal of Medicine 2000 342 1887-1892. (Pubitemid 30419054)
5. Benson K & Hartz A. A comparison of observational studies and randomized, controlled trials. New England Journal of Medicine 2000 342 1878-1886. (Pubitemid 30419053)
6. Hoybye C, Jönsson P, Monson JP, Kołtowska-Häggström M, Hána V, Geffner M & Abs R. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset growth hormone deficiency. European Journal of Endocrinology 2007 157 589-596. (Pubitemid 350187375)
7. Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Goth MI, Koltowska-Haggstrom M, Monson JP, Verhelst J &Wilton P. Isolated growth hormone deficiency in adult patients, baseline characteristics and response to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Hormone & IGF Research 2005 15 349-359.
8. Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P & Wuster C. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly and Cushing's disease. European Journal of Endocrinology 2002 146 67-74. (Pubitemid 34130119)
9. Keleştimur F, Jonsson P, Molvalilar S, Gomez JM, Auernhammer CJ, Colak R, Koltowska-Häggström M & Goth MI. Sheehan's syndrome: baseline characteristics and effects of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database. European Journal of Endocrinology 2005 152 581-587. (Pubitemid 40584769)